Nucleic acids encoding antibodies against IL-1 beta
US11407824B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2020 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Feb 6, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/545
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to anti-IL-1 beta antibodies and in particular to monovalent high potency IL-1 beta-binding antibody fragments being highly stable. Such antibodies can be used in the treatment of inflammatory and other diseases as well as in diagnostics. Also provided are related nucleic acids, vectors, cells, and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.